The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAccrol Gp Regulatory News (ACRL)

  • This share is currently suspended. It was suspended at a price of 38.80

Share Price Information for Accrol Gp (ACRL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 38.80
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: -38.80 (-100.00%)
Open: 38.80
High: 38.80
Low: 38.80
Prev. Close: 38.80
ACRL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Licensing Agreement with Unilever

1 Mar 2023 07:00

RNS Number : 4041R
Accrol Group Holdings PLC
01 March 2023
 

1 March 2023

 

Accrol Group Holdings plc

("Accrol, the "Group" or the "Company")

 

LICENSING AGREEMENT WITH UNILEVER

 

The Board of Accrol (AIM: ACRL), the UK's leading independent tissue converter, is pleased to announce that, further to its stated strategy to expand into higher margin, third party licensed brands, it has entered an agreement with one of the world's largest consumer goods companies, Unilever plc ("Unilever"), to exclusively produce and sell a kitchen towel product under its Lifebuoy brand. 

 

Lifebuoy is the third most-chosen FMCG brand globally, being picked by consumers more than a billion times a year1. With over 70% brand awareness amongst consumers in the UK2, the Lifebuoy kitchen towel product expands Accrol's offering to include those consumers who prefer to buy global brands but are seeking best-value.  Source: 1Kantar's Brand Footprint 2021 2Unilever consumer data 2022

 

The Board believes that, following significant investment over the last four years, Accrol is now the lowest cost tissue-products manufacturer in the UK. This operational efficiency is expected to deliver Lifebuoy kitchen towel at a retail price-point positioned between the current market leader and its private label equivalents, demonstrating exceptional value and quality from a trusted global brand.

 

The Lifebuoy range includes two of the top four selling SKUs in the UK's major retailers and the addition of a kitchen towel product will enhance the household product offering for Unilever.

 

Gareth Jenkins, Chief Executive Officer of Accrol, said:

 

"Last month, we laid out our strategic plans for the business, which included the expansion of the Group's activities into higher margin, third party licensed brands. That Unilever has chosen Accrol to bring Lifebuoy kitchen towel to market is testament to the capability of our business and our increasingly strong reputation in the market."

 

Graham Cox, Managing Director of Accrol's Tissue Division, who is leading the development of Accrol's licensed business model, added:

 

"This agreement with Unilever, our first licensing deal, is a step change for Accrol and continues our progress as a market and industry leader. The Group has ambition and continues to explore new opportunities, including further licensing deals, to bring high quality products at affordable prices to the UK consumer."

 

As announced in the Strategic Review Outcomes on 24 January 2023, the Group's licensed business model is expected to generate 10% to 20% of Group revenues in the medium to long-term.

 

Production of the Lifebuoy kitchen towel product requires no additional capital investment.

 

For further information, please contact:

 

 

Accrol Group Holdings plc

Dan Wright, Executive Chairman

Via Belvedere Communications

Gareth Jenkins, Chief Executive Officer

Richard Newman, Chief Financial Officer

 

Zeus (Nominated Adviser & Broker) 

 

Dan Bate / Jordan Warburton

Tel: +44 (0) 161 831 1512

Dominic King

Tel: +44 (0) 203 829 5000

Liberum Capital Limited (Joint Broker)

Tel: +44 (0) 20 3100 2222

Clayton Bush / Edward Thomas

Belvedere Communications Limited

Cat Valentine

Tel: +44 (0) 7715 769 078

Keeley Clarke

Tel: +44 (0) 7967 816 525

accrolpr@belvederepr.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGRSEUFWAEDSEDE
Date   Source Headline
18th May 20219:06 amRNSSecond Price Monitoring Extn
18th May 20219:00 amRNSPrice Monitoring Extension
18th May 20217:00 amRNSTrading Update
9th Apr 20217:00 amRNSAcquisition of highly scalable wet wipes business
8th Apr 20216:04 pmRNSCorrection: TR-1
8th Apr 20215:58 pmRNSCorrection: TR-1
30th Mar 20217:00 amRNSTR-1
18th Mar 20213:23 pmRNSTR-1
5th Mar 20217:11 amRNSImplementation of LTIP and PDMR dealing
14th Jan 20217:00 amRNSPDMR Dealings
12th Jan 20217:00 amRNSHalf Year Results
7th Jan 20217:00 amRNSOnline HY 21 Investor Presentation
17th Dec 20207:00 amRNSNotice of Half Year Results
15th Dec 20207:00 amRNSOnline Investor Presentation
14th Dec 202011:05 amRNSSecond Price Monitoring Extn
14th Dec 202011:00 amRNSPrice Monitoring Extension
14th Dec 20209:05 amRNSSecond Price Monitoring Extn
14th Dec 20209:00 amRNSPrice Monitoring Extension
11th Dec 20208:51 amRNSTR-1
2nd Dec 20207:00 amRNSAppointment of Chief Financial Officer
27th Nov 202012:48 pmRNSTR-1
26th Nov 20207:00 amRNSTR-1
25th Nov 20207:00 amRNSCompletion of Acquisition
24th Nov 20201:54 pmRNSTR-1
24th Nov 20201:44 pmRNSTR-1
24th Nov 202011:28 amRNSTR-1
24th Nov 202010:54 amRNSTR-1
24th Nov 20207:00 amRNSPDMR Dealing
23rd Nov 20208:00 amRNSAdmission of Shares & Total Voting Rights
20th Nov 202011:32 amRNSResult of General Meeting
20th Nov 20207:00 amRNSResult of Open Offer
6th Nov 202011:55 amRNSTR-1
4th Nov 20205:13 pmRNSPosting of Circular
3rd Nov 20207:00 amRNSConfirmation of Successful Placing
2nd Nov 20204:59 pmRNSAcquisition and Launch of ABB
2nd Nov 20207:00 amRNSCOVID-19 Business Update
27th Oct 20202:44 pmRNSResult of AGM
25th Sep 20208:00 amRNSNotice of AGM and Posting of Accounts
2nd Sep 20207:00 amRNSAudited Final Results
25th Aug 20207:00 amRNSNotice of Results and Online Investor Presentation
22nd May 202012:40 pmRNSTR-1
21st May 20202:25 pmRNSTR-1
6th May 20207:00 amRNSTrading Update
25th Mar 202010:19 amRNSTR-1
23rd Mar 202011:35 amRNSTR-1
17th Mar 20207:00 amRNSAppointment of Joint Broker
4th Mar 20207:00 amRNSTR-1
3rd Mar 20209:41 amRNSTR-1
29th Jan 20207:00 amRNSDirector's Dealing
21st Jan 20209:13 amRNSTR-1

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.